Effects of Cervicothoracic Mobility Program on Low Back Pain
CompletedNot applicableNCT05347251
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The study will be a randomized control trial to determine the effects of the cervicothoracic mobility program on pain, range of motion, and function in patients with chronic back pain. The purposive sampling technique will be used. A sample of 44 patients will be taken and divided into two groups each with 22 patients. Group A will be the experimental group and group B will be the control group. The experimental group will receive cervical mobility and thoracic mobility along with conventional physical therapy protocols like hot packs and exercise therapy protocol. Group B will be the control group and will receive the conventional physical therapy protocol like the hot pack and exercise therapy protocol. Exercise therapy includes the strengthening and stretching exercises of both neck and back muscles. The session will be around 40 to 45 min for each patient with three sessions per week on alternate days. A total of 3-week treatment program will be given to the patients and an assessment of the patient's pain, range of motion, and function with NPRS (numeric pain rating scale), goniometer, and ODI (Oswestry disability index) will be done at the baseline and after the completion of treatment at three weeks.
Study details
- Official title
- Effects of Cervicothoracic Mobility Program on Pain, Range of Motion and Function in Patients With Chronic Back Pain
- Conditions
- Interventions
- Other: Cervicothoracic mobility program
- Other: Conventional Treatment
- Sponsor
- Riphah International University
- Start date
- 2022-04-25
- Primary completion
- 2022-12-30
- Sex
- All
- Age range
- from 18 Years to 50 Years
- Results posted
- No results posted in this snapshot
- Countries
- Pakistan
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Both genders. * Age 18-50 years. NPRS between 3 and 6 * Subjects diagnosed with chronic back pain with minimum 6 months of chronicity * ODI score 21 to 40 * There should be no radiating pain to legs of participants. Exclusion Criteria: * Patients with Systemic soft tissue disease and bony disease will be excluded from the study. * Pregnant women will be excluded from the study. * Patients with previous orthopedic and neurosurgical surgery will be excluded from the study. * Patients with any Red flags (Ankylosing spondylitis, spondylolisthesis, Slipped discs, spinal tumor, spinal stenosis, cauda equine syndrome, and spine infection) will be excluded. * Patients with a positive Faber test for SIJ dysfunction will be excluded
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05347251